Cancer-Related Fatigue in Patients With and Survivors of Hodgkin Lymphoma: The Impact on Treatment Outcome and Social Reintegration

被引:74
作者
Behringer, Karolin [1 ]
Goergen, Helen [1 ]
Mueller, Horst [1 ]
Thielen, Indra [1 ]
Brillant, Corinne [1 ]
Kreissl, Stefanie [1 ]
Halbsguth, Teresa Veronika [3 ]
Meissner, Julia [4 ]
Greil, Richard [6 ]
Moosmann, Peter [7 ,8 ]
Shonukan, Oluwatoyin [9 ]
Rueffer, Jens Ulrich [2 ]
Flechtner, Hans-Henning [5 ]
Fuchs, Michael [1 ]
Diehl, Volker [1 ]
Engert, Andreas [1 ]
Borchmann, Peter [1 ]
机构
[1] Univ Hosp Cologne, Cologne, Germany
[2] German Fatigue Soc, Cologne, Germany
[3] Univ Hosp Frankfurt, Frankfurt, Germany
[4] Heidelberg Univ, Heidelberg, Germany
[5] Otto von Guericke Univ, Magdeburg, Germany
[6] Paracelsus Med Univ, Salzburg, Austria
[7] Cantonal Hosp Aarau AG, Aarau, Switzerland
[8] Swiss Grp Clin Canc Res, Bern, Switzerland
[9] Boston Univ, Sch Publ Hlth, Boston, MA USA
关键词
QUALITY-OF-LIFE; RANDOMIZED CONTROLLED-TRIAL; COGNITIVE-BEHAVIOR THERAPY; NON-INFERIORITY TRIAL; DISEASE SURVIVORS; CLINICAL-TRIALS; BREAST-CANCER; OPEN-LABEL; EXERCISE; ONCOLOGY;
D O I
10.1200/JCO.2016.67.7450
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Cancer-related fatigue occurs frequently in patients with Hodgkin lymphoma (HL) and has a major impact on their quality of life. We hypothesized that severe fatigue (sFA) might have an impact on patients' treatment outcome and social reintegration. Methods Of 5,306 patients enrolled in the German Hodgkin Study Group's fifth generation of clinical trials in HL (HD13, HD14, and HD15; nonqualified and older [>60 years] patients excluded), 4,529 provided data on health-related quality of life. We describe sFA (defined as a score >= 50 on the 0 to 100 scale from the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30) before and up to 9 years after therapy and analyze its impact on treatment outcome and social reintegration. Results The proportion of patients reporting sFA was 37% at baseline and ranged from 20% to 24% during follow-up. Baseline sFA was associated with significantly impaired progression-free survival and a trend to impaired overall survival, which can be overcome in patients receiving highly effective HL therapies as applied in our fifth-generation trials. Our analysis revealed a significant negative association of sFA and employment in survivors: 5 years after therapy, 51% and 63% of female and male survivors, respectively, with sFA were working or in professional education, compared with 78% and 90% without sFA, respectively (P < .001 adjusted for age, sex, stage, baseline employment status, and treatment outcome). sFA was also associated with financial problems and the number of visits to a general practitioner and medical specialists. Conclusion sFA is an important factor preventing survivors from social reintegration during follow-up. This observation underscores the need to address fatigue as a significant diagnosis when treating patients with and survivors of cancer. (C) 2016 by American Society of Clinical Oncology
引用
收藏
页码:4329 / +
页数:17
相关论文
共 31 条
  • [1] THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY
    AARONSON, NK
    AHMEDZAI, S
    BERGMAN, B
    BULLINGER, M
    CULL, A
    DUEZ, NJ
    FILIBERTI, A
    FLECHTNER, H
    FLEISHMAN, SB
    DEHAES, JCJM
    KAASA, S
    KLEE, M
    OSOBA, D
    RAZAVI, D
    ROFE, PB
    SCHRAUB, S
    SNEEUW, K
    SULLIVAN, M
    TAKEDA, F
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) : 365 - 376
  • [2] Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial
    Behringer, Karolin
    Goergen, Helen
    Hitz, Felicitas
    Zijlstra, Josee M.
    Greil, Richard
    Markova, Jana
    Sasse, Stephanie
    Fuchs, Michael
    Topp, Max S.
    Soekler, Martin
    Mathas, Stephan
    Meissner, Julia
    Wilhelm, Martin
    Koch, Peter
    Lindemann, Hans-Walter
    Schalk, Enrico
    Semrau, Robert
    Kriz, Jan
    Vieler, Tom
    Bentz, Martin
    Lange, Elisabeth
    Mahlberg, Rolf
    Hassler, Andre
    Vogelhuber, Martin
    Hahn, Dennis
    Mezger, Joerg
    Krause, Stefan W.
    Skoetz, Nicole
    Boell, Boris
    von Tresckow, Bastian
    Diehl, Volker
    Hallek, Michael
    Borchmann, Peter
    Stein, Harald
    Eich, Hans
    Engert, Andreas
    [J]. LANCET, 2015, 385 (9976) : 1418 - 1427
  • [3] Screening, Assessment, and Management of Fatigue in Adult Survivors of Cancer: An American Society of Clinical Oncology Clinical Practice Guideline Adaptation
    Bower, Julienne E.
    Bak, Kate
    Berger, Ann
    Breitbart, William
    Escalante, Carmelita P.
    Ganz, Patricia A.
    Schnipper, Hester Hill
    Lacchetti, Christina
    Ligibel, Jennifer A.
    Lyman, Gary H.
    Ogaily, Mohammed S.
    Pirl, William F.
    Jacobsen, Paul B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (17) : 1840 - U127
  • [4] Cytokine Genetic Variations and Fatigue Among Patients With Breast Cancer
    Bower, Julienne E.
    Ganz, Patricia A.
    Irwin, Michael R.
    Castellon, Steven
    Arevalo, Jesusa
    Cole, Steven W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (13) : 1656 - +
  • [5] Randomized Controlled Trial of the Effects of Aerobic Exercise on Physical Functioning and Quality of Life in Lymphoma Patients
    Courneya, Kerry S.
    Sellar, Christopher M.
    Stevinson, Clare
    McNeely, Margaret L.
    Peddle, Carolyn J.
    Friedenreich, Christine M.
    Tankel, Keith
    Basi, Sanraj
    Chua, Neil
    Mazurek, Alex
    Reiman, Tony
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (27) : 4605 - 4612
  • [6] Chronic fatigue in Hodgkin lymphoma survivors and associations with anxiety, depression and comorbidity
    Daniels, L. A.
    Oerlemans, S.
    Krol, A. D. G.
    Creutzberg, C. L.
    van de Poll-Franse, L. V.
    [J]. BRITISH JOURNAL OF CANCER, 2014, 110 (04) : 868 - 874
  • [7] Persisting fatigue in Hodgkin lymphoma survivors: a systematic review
    Daniels, Laurien A.
    Oerlemans, Simone
    Krol, Augustinus D. G.
    van de Poll-Franse, Lonneke V.
    Creutzberg, Carien L.
    [J]. ANNALS OF HEMATOLOGY, 2013, 92 (08) : 1023 - 1032
  • [8] Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial
    Engert, Andreas
    Haverkamp, Heinz
    Kobe, Carsten
    Markova, Jana
    Renner, Christoph
    Ho, Antony
    Zijlstra, Josee
    Kral, Zdenek
    Fuchs, Michael
    Hallek, Michael
    Kanz, Lothar
    Doehner, Hartmut
    Doerken, Bernd
    Engel, Nicole
    Topp, Max
    Klutmann, Susanne
    Amthauer, Holger
    Bockisch, Andreas
    Kluge, Regine
    Kratochwil, Clemens
    Schober, Otmar
    Greil, Richard
    Andreesen, Reinhard
    Kneba, Michael
    Pfreundschuh, Michael
    Stein, Harald
    Eich, Hans Theodor
    Mueller, Rolf-Peter
    Dietlein, Markus
    Borchmann, Peter
    Diehl, Volker
    [J]. LANCET, 2012, 379 (9828) : 1791 - 1799
  • [9] Quality of life assessment in Hodgkin's disease:: A new comprehensive approach -: First experiences from the EORTC/GELA and GHSG trials
    Flechtner, H
    Rüffer, JU
    Henry-Amar, M
    Mellink, WAM
    Sieber, M
    Fermé, C
    Eghbali, H
    Josting, A
    Diehl, V
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 147 - 154
  • [10] PSYCHOSOCIAL PROBLEMS AMONG SURVIVORS OF HODGKINS-DISEASE
    FOBAIR, P
    HOPPE, RT
    BLOOM, J
    COX, R
    VARGHESE, A
    SPIEGEL, D
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (05) : 805 - 814